arrow
X

X. Mirabel

centre oscar lambret
H指数:38
被引数:5,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Total-body irradiation-based versus chemotherapy alone as myeloablative conditioning regimen prior to hematopoietic allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia: a multi-institutional study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

全身照射为基础与单纯化疗作为成人急性淋巴细胞白血病患者造血同种异基因干细胞移植前骨髓清除性预处理方案:一项来自法语区骨髓移植与细胞治疗学会(SFGM-TC)的多中心研究

2025-10-220
PRE
Rectal cancer- French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR)
2025-03-010
OAAI
Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trial

Nivolumab和低分割放射治疗在晚期黑色素瘤患者中的应用:一项II期临床试验

2025-02-010
PRE
Final and exploratory results of a phase I trial evaluating novel radioenhancer NBTXR3 activated by radiotherapy in cisplatin-ineligible LA HNSCC patients

I期临床试验的最终和探索性结果,评估由放疗激活的新型放射增敏剂NBTXR3在顺铂不耐受的局部晚期头颈鳞癌(LA HNSCC)患者中的疗效。

2024-12-010
PRE
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
2024-02-0120
OAAI
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma- randomized phase 2 trial ARION UCGI 33/ PRODIGE 67: the study protocol
2023-10-122
OAAI
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD
2023-09-011
OAAI
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
2023-04-013
OAAI
Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer
2022-12-026
OAAI